In the healthcare supply chain world, the year 2020 created a notable split. Even those not directly involved in the healthcare industry, that would otherwise have no vested interest in healthcare-specific supply chain knowledge, felt the...
For the past two and a half years, organizations have had to learn to operate across remote and hybrid environments at an unprecedented rate. Initially, the issues that stemmed from immediate and widespread remote work were plentiful:...
The United States Food and Drug Administration (FDA) estimates that more than 30 million people living in the U.S. are affected by over 7,000 rare diseases. Many of these rare diseases do not have a known...
Cold supply chains are necessary to ensure the efficacy of certain medications, vaccines and other biopharmaceutical products, but the addition of extreme temperatures presents new obstacles that can make the process even more difficult to manage...
Your success as a pharmaceutical company heavily relies on the implementation of a quality management system. With ever-changing FDA regulations and technological advancements, the demand for solid infrastructure with quality in mind is increasing. Truthfully, the...
The U.S. Food and Drug Administration (FDA) recently announced the proposed rule, which aims to create a uniform national licensing standard for wholesale distributors and third-party logistics providers (3PLs). Historically, states have set their own standards for...
There are a variety of challenges that patients may face when accessing medication. In fact, a 2019 study on medication access identified 17 distinct barriers that patients must overcome, including costs, transportation, and geographical characteristics that can create...
With all the challenges facing the global supply chain in recent years, including materials and labor shortages, it comes as no surprise that third-party logistics (3PL) providers are looking to utilize cutting edge technologies to create...
Tom Hart, COO of BioCare, a specialty distributor of medications, discusses the ways to combat the cold chain-warmer temperatures dilemma, along with his future outlook on the industry supply chain as a whole.
The healthcare industry is one of the most highly regulated out there — and for good reason. When it comes to developing and then getting life-saving medications to patients, there is little room for error. Regardless...
